2017 Q1 Form 10-Q Financial Statement

#000156459017009918 Filed on May 09, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q1
Revenue $372.0M $352.0M
YoY Change 5.68% -3.03%
Cost Of Revenue $17.00M $16.00M
YoY Change 6.25% 23.08%
Gross Profit $355.0M $336.0M
YoY Change 5.65% -4.0%
Gross Profit Margin 95.43% 95.45%
Selling, General & Admin $301.0M $270.0M
YoY Change 11.48% 42.11%
% of Gross Profit 84.79% 80.36%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $27.00M $24.00M
YoY Change 12.5% 71.43%
% of Gross Profit 7.61% 7.14%
Operating Expenses $328.0M $294.0M
YoY Change 11.56% 54.74%
Operating Profit $27.00M $42.00M
YoY Change -35.71% -53.33%
Interest Expense -$2.000M -$4.000M
YoY Change -50.0% -300.0%
% of Operating Profit -7.41% -9.52%
Other Income/Expense, Net -$2.000M
YoY Change
Pretax Income $25.00M $38.00M
YoY Change -34.21% -55.81%
Income Tax $12.00M $11.00M
% Of Pretax Income 48.0% 28.95%
Net Earnings $13.00M $29.00M
YoY Change -55.17% -53.97%
Net Earnings / Revenue 3.49% 8.24%
Basic Earnings Per Share $0.09 $0.20
Diluted Earnings Per Share $0.09 $0.20
COMMON SHARES
Basic Shares Outstanding 143.6M 145.4M
Diluted Shares Outstanding 144.7M 146.9M

Balance Sheet

Concept 2017 Q1 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $746.0M $692.0M
YoY Change 7.8% 11.08%
Cash & Equivalents $731.0M $653.0M
Short-Term Investments $15.00M $39.00M
Other Short-Term Assets $25.00M $28.00M
YoY Change -10.71% -33.33%
Inventory
Prepaid Expenses
Receivables $232.0M $244.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.003B $964.0M
YoY Change 4.05% 7.83%
LONG-TERM ASSETS
Property, Plant & Equipment $262.0M $252.0M
YoY Change 3.97% 11.5%
Goodwill $737.0M
YoY Change
Intangibles $172.0M
YoY Change
Long-Term Investments $3.000M $17.00M
YoY Change -82.35% -10.53%
Other Assets $67.00M $72.00M
YoY Change -6.94% 84.62%
Total Long-Term Assets $1.271B $1.250B
YoY Change 1.68% 4.17%
TOTAL ASSETS
Total Short-Term Assets $1.003B $964.0M
Total Long-Term Assets $1.271B $1.250B
Total Assets $2.274B $2.214B
YoY Change 2.71% 5.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.00M $15.00M
YoY Change -20.0% -42.31%
Accrued Expenses $76.00M $134.0M
YoY Change -43.28% 100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $1.000M
YoY Change -100.0% -97.5%
Long-Term Debt Due $7.000M $1.000M
YoY Change 600.0% -97.5%
Total Short-Term Liabilities $452.0M $432.0M
YoY Change 4.63% -4.42%
LONG-TERM LIABILITIES
Long-Term Debt $210.0M $110.0M
YoY Change 90.91% -56.0%
Other Long-Term Liabilities $215.0M $192.0M
YoY Change 11.98% 10.34%
Total Long-Term Liabilities $425.0M $302.0M
YoY Change 40.73% -28.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $452.0M $432.0M
Total Long-Term Liabilities $425.0M $302.0M
Total Liabilities $890.0M $750.0M
YoY Change 18.67% -18.03%
SHAREHOLDERS EQUITY
Retained Earnings $853.0M
YoY Change
Common Stock $758.0M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $93.00M
YoY Change
Treasury Stock Shares $6.925M $1.417M
Shareholders Equity $1.384B $1.464B
YoY Change
Total Liabilities & Shareholders Equity $2.274B $2.214B
YoY Change 2.71% 5.73%

Cashflow Statement

Concept 2017 Q1 2016 Q1
OPERATING ACTIVITIES
Net Income $13.00M $29.00M
YoY Change -55.17% -53.97%
Depreciation, Depletion And Amortization $27.00M $24.00M
YoY Change 12.5% 71.43%
Cash From Operating Activities $134.0M $124.0M
YoY Change 8.06% 25.25%
INVESTING ACTIVITIES
Capital Expenditures $18.00M $17.00M
YoY Change 5.88% -45.16%
Acquisitions
YoY Change
Other Investing Activities $116.0M $28.00M
YoY Change 314.29% -1033.33%
Cash From Investing Activities $98.00M $11.00M
YoY Change 790.91% -132.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $150.0M $1.000M
YoY Change 14900.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -114.0M -98.00M
YoY Change 16.33% 3166.67%
NET CHANGE
Cash From Operating Activities 134.0M 124.0M
Cash From Investing Activities 98.00M 11.00M
Cash From Financing Activities -114.0M -98.00M
Net Change In Cash 119.0M 37.00M
YoY Change 221.62% -40.32%
FREE CASH FLOW
Cash From Operating Activities $134.0M $124.0M
Capital Expenditures $18.00M $17.00M
Free Cash Flow $116.0M $107.0M
YoY Change 8.41% 57.35%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
612000000
CY2017Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
37000000
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
67000000
CY2017Q1 us-gaap Assets
Assets
2274000000
CY2017Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
12000000
CY2017Q1 us-gaap Customer Advances Current
CustomerAdvancesCurrent
218000000
CY2017Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
87000000
CY2016Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
10000000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
127000000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
423000000
CY2017Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
210000000
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
91000000
CY2017Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
13000000
CY2017Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
215000000
CY2016Q4 us-gaap Liabilities
Liabilities
736000000
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
831000000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
945000000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-77000000
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
197000000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
1502000000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2238000000
CY2016Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
42000000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
67000000
CY2016Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
80000000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
9000000
CY2017Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
128000000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
111000000
CY2017Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
87000000
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
80000000
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2017Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1600000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1600000000
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
135318415
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
134706467
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
128393005
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
131310980
CY2017Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
6925410
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
3395487
CY2017Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000000
CY2017Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
150000000
CY2017Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1000000
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
65000000
CY2016Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
14000000
CY2016Q1 us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
72000000
CY2016Q1 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-1000000
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18000000
CY2016Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
16000000
CY2017Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
102000000
CY2016Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
33000000
CY2017Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
14000000
CY2016Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
11000000
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
98000000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
11000000
CY2017Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
150000000
CY2016Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1000000
CY2017Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3000000
CY2017Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
13000000
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-114000000
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-98000000
CY2017Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
1000000
CY2016Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
2000000
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
119000000
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
39000000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
614000000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
653000000
CY2017Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
3000000
CY2016Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
3000000
CY2017Q1 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accounting Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">We use estimates and assumptions in the preparation of our unaudited condensed consolidated financial statements in accordance with GAAP. Our estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of our unaudited condensed consolidated financial statements. These estimates and assumptions also affect the reported amount of net income or loss during any period. Our actual financial results could differ significantly from these estimates. The significant estimates underlying our unaudited condensed consolidated financial statements include: (i) recognition and recoverability of goodwill, intangible and other long-lived assets; (ii) accounting for income taxes; and (iii) stock-based compensation. </p></div>
CY2017Q1 trip Number Of Markets With Localized Websites
NumberOfMarketsWithLocalizedWebsites
48
CY2017Q1 trip Number Of Languages Worldwide
NumberOfLanguagesWorldwide
28
CY2017Q1 trip Number Of Other Travel Brands
NumberOfOtherTravelBrands
23
CY2017Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19000000
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19000000
CY2017Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
7000000
CY2016Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
7000000
CY2017Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
12000000
CY2016Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
12000000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0191
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0128
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y4M6D
CY2016Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y2M5D
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4153
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4164
CY2017Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
516000
CY2016Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1185000
CY2017Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
569000
CY2016Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
273000
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6447000
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3758000
CY2017Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
731000000
CY2017Q1 us-gaap Cash
Cash
727000000
CY2017Q1 trip Cash And Cash Equivalents And Available For Sale Securities Amortized Cost
CashAndCashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost
749000000
CY2017Q1 trip Cash And Cash Equivalents And Available For Sale Securities
CashAndCashEquivalentsAndAvailableForSaleSecurities
749000000
CY2016Q4 us-gaap Cash
Cash
595000000
CY2016Q4 trip Cash And Cash Equivalents And Available For Sale Securities Amortized Cost
CashAndCashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost
746000000
CY2016Q4 trip Cash And Cash Equivalents And Available For Sale Securities
CashAndCashEquivalentsAndAvailableForSaleSecurities
746000000
CY2017Q1 trip Cash And Cash Equivalents Maximum Maturity Period
CashAndCashEquivalentsMaximumMaturityPeriod
P90D
CY2016 trip Cash And Cash Equivalents Maximum Maturity Period
CashAndCashEquivalentsMaximumMaturityPeriod
P90D
CY2017Q1 trip Marketable Securities Long Term Maximum Maturity Period
MarketableSecuritiesLongTermMaximumMaturityPeriod
P3Y
CY2016 trip Marketable Securities Long Term Maximum Maturity Period
MarketableSecuritiesLongTermMaximumMaturityPeriod
P3Y
CY2017Q1 trip Marketable Securities Long Term Minimum Maturity Period
MarketableSecuritiesLongTermMinimumMaturityPeriod
P1Y
CY2016 trip Marketable Securities Long Term Minimum Maturity Period
MarketableSecuritiesLongTermMinimumMaturityPeriod
P1Y
CY2017Q1 trip Maximum Remaining Maturity Period For Short Term Securities
MaximumRemainingMaturityPeriodForShortTermSecurities
P12M
CY2016 trip Maximum Remaining Maturity Period For Short Term Securities
MaximumRemainingMaturityPeriodForShortTermSecurities
P12M
CY2017Q1 trip Minimum Maturity Period For Short Term Securities
MinimumMaturityPeriodForShortTermSecurities
P90D
CY2016 trip Minimum Maturity Period For Short Term Securities
MinimumMaturityPeriodForShortTermSecurities
P90D
CY2016Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1000000
CY2017Q1 trip Derivative Instruments Non Designated As Hedging Instruments Description
DerivativeInstrumentsNonDesignatedAsHedgingInstrumentsDescription
Our current forward contracts are not designated as hedges and have current maturities of less than 90 days
CY2017Q1 us-gaap Cost Method Investments
CostMethodInvestments
14000000
CY2017Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.480
CY2016Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.237
CY2017Q1 us-gaap Income Tax Examination Interest Accrued
IncomeTaxExaminationInterestAccrued
6000000
CY2017Q1 us-gaap Income Tax Examination Penalties Accrued
IncomeTaxExaminationPenaltiesAccrued
0
CY2017Q1 trip Income Tax Reconciliation Change In Cost Sharing Treatment Of Stock Based Compensation
IncomeTaxReconciliationChangeInCostSharingTreatmentOfStockBasedCompensation
-1000000
CY2016Q1 trip Income Tax Reconciliation Change In Cost Sharing Treatment Of Stock Based Compensation
IncomeTaxReconciliationChangeInCostSharingTreatmentOfStockBasedCompensation
-1000000
CY2017Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
28000000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
53000000
CY2017Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
48000000
CY2016Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
37000000
CY2017Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
46000000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
37000000
CY2017Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
250000000
CY2017Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
3529923
CY2017Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
42.49
CY2017Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
100000000
CY2017Q1 trip Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
73000000
CY2016Q1 trip Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
85000000

Files In Submission

Name View Source Status
0001564590-17-009918-index-headers.html Edgar Link pending
0001564590-17-009918-index.html Edgar Link pending
0001564590-17-009918.txt Edgar Link pending
0001564590-17-009918-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
trip-10q_20170331.htm Edgar Link pending
trip-20170331.xml Edgar Link completed
trip-20170331.xsd Edgar Link pending
trip-20170331_cal.xml Edgar Link unprocessable
trip-20170331_def.xml Edgar Link unprocessable
trip-20170331_lab.xml Edgar Link unprocessable
trip-20170331_pre.xml Edgar Link unprocessable
trip-ex101_967.htm Edgar Link pending
trip-ex311_8.htm Edgar Link pending
trip-ex312_7.htm Edgar Link pending
trip-ex321_6.htm Edgar Link pending
trip-ex322_9.htm Edgar Link pending